The liposome drug delivery market has been drawing immense attention of late because of the high demand in targeted drug delivery systems. In fact, Liposomes are such spherical vesicles of lipid bilayers that allow drugs of both the hydrophilic and hydrophobic nature for encapsulation thus making them highly versatile carriers of a wide spectrum of therapeutic agents.
The Liposome Drug Delivery Market was valued at US$ 4.2 billion in 2021 and is expected to reach US$ 11.5 billion by 2031. The market is expected to register a CAGR of 8.3% from 2023–2031.
Market Segmentations
By Product
- Liposomal Doxorubicin
- Liposomal Paclitaxel
- Liposomal Amphotericin B
By Technology
- Stealth Liposome Technology
- Non-PEGylated Liposome Technology
- DepoFoam Liposome Technology
- Lysolipid Thermally Sensitive Liposome
By Application
- Fungal Diseases
- Cancer Therapy
- Pain Management
- Viral Vaccines
- Photodynamic Therapy
Please follow and like us:
